Loading…
← CockpitCompetitor Analysis › VMD Viemed Healthcare, Inc.Open in the cockpit ↗

Viemed Healthcare, Inc.VMDCompetitor analysis, valuation and peers

United States · USD·Health Care›Hospital/Nursing Management
Momentum neutral 47
Mkt cap
$333M
US dollars, full cap
Free float
86%
of shares outstanding
$/day
$1.96M
20-day average traded
Fwd P/E
17.4×
forward earnings
ROIC−WACC
+3.2 pp
WACC 10.2%
Hurdle
-9 pp
Req g minus delivered
Next earnings
112 days
10 Mar 2027
Close · USD$8.78
1D-3.2%
1W-3.8%
1M-10.4%
3M+2.5%
6M-9.3%
YTD+18.2%
1Y+39.6%
ATR %3.8%
Beta0.46
52w lowhigh30.4% off high

What Viemed Healthcare does

Employees: 1,382

Viemed Healthcare at a glance

Size Viemed Healthcare (VMD) is a United States Health Care company (Hospital/Nursing Management) with a market value of $333M, the 2990th largest of 3,085 United States companies the cockpit tracks. Shares closed at $8.78 on 18 Nov 2026.

Performance Over six months the shares fell 9.3%, against -3.4% for the median peer and -2.2% for the United States market (cap-weighted) — 8th lowest of 19 in its peer set.

Growth Revenue grew 21.8% over the last twelve months (peer median +10.9%); the operating margin is 8.4% (peer median 10.7%).

Valuation It trades at 17.4× forward earnings against a peer median of 22.5× (5th cheapest of 14).

Price implies For today's price to make sense, revenue must grow about 7% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -9 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 3.2 points above its cost of capital (10.2% WACC).

Next results Next results expected around 10 Mar 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026Peer median 95VMD 91
Six months, rebased to 100: Viemed Healthcare against the median of its 20 peers (local-currency closes).

Viemed Healthcare financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$310M$270M$224M$183M$139M
Revenue growth—+21%+23%+32%—
Gross profit$177M$154M$132M$111M$83.7M
EBITDA$56.4M$50.4M$40.3M$37.4M$24.2M
Net income$15.6M$14.9M$11.3M$10.2M$6.22M
Free cash flow$21.4M$11.9M$1.32M$19.1M$4.85M
Capital expenditure$32.5M$40.0M$37.8M$26.1M$22.9M
Total debt$9.28M$15.9M$6.87M$10.3M$694,000

Quarterly statements and history in the cockpit →

Viemed Healthcare competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%+40%QC7301103INDRAMEDCO26093012391515VOX6062GHCARTEMISMEDKOVAIHCGGDSJLHLRHKPARKHOSPSVMD6-month return →1-month return →
Up and to the right = strong over both horizons. Viemed Healthcare is the large dot.

Fundamentals: revenue growth against valuation

0%+5%+10%+15%+20%0×25×50×75×QC7INDRAMEDCO3012391515VOX6062GHCARTEMISMEDHCGCBAVJLHLPARKHOSPSVMDRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Viemed Healthcare is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%QC7301103KMCSHILINDRAMEDCO26093012391515VOXGHCARTEMISMEDKOVAIA50GDSCBAVPARKHOSPSVMDGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Viemed Healthcare is the large dot.

Viemed Healthcare competitors and peer comparison

How Viemed Healthcare compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Viemed Healthcare against its 20 peers (data as of 18 Nov 2026)
MeasureVMDPeer medianRank in peer set
1-month return-10.4%+2.1%4th lowest of 20
6-month return-9.3%-3.4%8th lowest of 19
Distance from 52-week high-30.4%-18.4%7th lowest of 21
Revenue growth (TTM)+21.8%+10.9%3rd highest of 21
Operating margin8.4%10.7%7th lowest of 21
Forward P/E17.4×22.5×5th cheapest of 14
Growth the price implies (Req g, 7 yrs)6.8%6.9%9th least demanding of 17
Growth delivered (Del g)+15.5%+15.9%9th highest of 17
Hurdle (Req g minus delivered)-8.7 pp-4.9 pp8th least demanding of 17
ROIC minus cost of capital+3.2 pp+0.6 pp9th highest of 21
EV / EBITDA5.9×14.6×2nd cheapest of 18
Net debt / EBITDA-0.0×0.6×6th least indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Viemed Healthcare VMDUnited States$333M-9%+22%8%17.4×6.8%+15.5%
Q & M Dental Group (Singapore) QC7.SISingapore$326M-26%+16%9%31.6×7.7%+7.5%
Liaoning He Eye Hospital 301103.SZChina$342M-20%+3%4%n/a-4.2%+5.4%
KMC Speciality Hospitals (India) KMCSHIL.NSIndia$346Mn/a+35%23%n/a19.0%+24.4%
Indraprastha Medical INDRAMEDCO.NSIndia$351M0%+11%15%15.9×14.9%+19.3%
Bayzed Health 2609.HKHong Kong$375M-58%-2%5%n/a14.7%+9.2%
Bright Eye Hospital 301239.SZChina$377M-26%+11%9%41.5×-5.1%+15.5%
China Resources Medical 1515.HKHong Kong$393M-10%0%6%5.4×-7.5%+26.3%
Voxel VOX.WAPoland$393M+59%+14%24%13.6×1.2%+12.2%
Charm Care 6062.TJapan$402M+57%+6%11%15.3×-0.4%+16.4%
Garofalo Health Care GHC.MIItaly$508M-3%+4%10%20.5×1.7%+18.3%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%42.3×48.5%+21.5%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%

Questions

Which companies are Viemed Healthcare's closest peers?
The cockpit's peer set: Q & M Dental Group (Singapore) (QC7.SI), Liaoning He Eye Hospital (301103.SZ), KMC Speciality Hospitals (India) (KMCSHIL.NS), Indraprastha Medical (INDRAMEDCO.NS), Bayzed Health (2609.HK), Bright Eye Hospital (301239.SZ), China Resources Medical (1515.HK), Voxel (VOX.WA).
Is Viemed Healthcare expensive compared with its peers?
On forward p/e it trades at 17.4× against a peer median of 22.5×, 5th cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about 7% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -9 pp: the price already allows for a slowdown.
How has Viemed Healthcare stock performed?
Over six months to 18 Nov 2026 the shares returned -9.3% against -3.4% for the median peer; over one year +39.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.